High-altitude illness and muscle physiology

Bulletin of the NYU Hospital for Joint Diseases

Volumn 65, Issue 1, 2007, Pages 72-77

  Weil, Wayne M ^d   Glassner, Philip J ^a   Bosco III, Joseph A ^a,b,c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; GINKGO BILOBA EXTRACT; NIFEDIPINE; SALMETEROL;

ACCLIMATIZATION; ALTITUDE; ALTITUDE DISEASE; ARTICLE; ATHLETE; BRAIN EDEMA; CLIMBING; CLINICAL FEATURE; ENDURANCE; FATALITY; HUMAN; INCIDENCE; LUNG EDEMA; MOUNTAINEERING; MUSCLE FUNCTION; PATHOPHYSIOLOGY; SKIING; SPORTS MEDICINE; TRAINING;

ALTITUDE; ANTI-INFLAMMATORY AGENTS; BRAIN EDEMA; CALCIUM CHANNEL BLOCKERS; DEXAMETHASONE; HUMANS; NIFEDIPINE; OXYGEN; PULMONARY EDEMA; RISK FACTORS;

EID: 33947212936     PISSN: 19369719     EISSN: 19369727     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tso E. High altitude illness. Emerg Med Clin North Am. 1992 May;10(2):231-47.
2. Gilbert DL. The first documented report of mountain sickness: The China or headache mountain story. Respir Physiol. 1983 Jun;52(3):315-26.
3. Dudley R. Limits to human locomotor performance: Phylogenetic origins and comparative perspectives. J Exp Biol. 2001 Sep;204(Pt 18):3235-40.
4. Rupert JL, Hochachka PW. Genetic approaches to understanding human adaptation to altitude in the Andes. J Exp Biol. 2001 Sep;204(Pt 18):3151-60.
5. Huey RB, Eguskitza X. Limits to human performance: Elevated risks on high mountains. J Exp Biol. 2001 Sep;204(Pt 18):3115-3119.
6. West JB. Barometric pressures on Mt. Everest: New data and physiological significance. J Appl Physiol. 1999 Mar;86(3):1062-6.
7. Peacock AJ. ABC of oxygen: Oxygen at high altitude, BMJ. 1998 Oct 17;317(7165):1063-6.
8. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993 Apr 15;118(8):587-92.
9. Dean AG, Yip R, Hoffmann RE. High incidence of mild acute mountain sickness in conference attendees at 10,000 foot altitude. J Wilderness Med. 1990;1:86-92.
10. Bartsch P, Grunig E, Hohenhaus E, Dehnert C. Assessment of high altitude tolerance in healthy individuals. High Alt Med Biol. 2001 Summer;2(2):287-96.
11. Roach RC, Houston CS, Honigman B, et al. How well do older persons tolerate moderate altitude? West J Med. 1995 Jan;162(1):32-6.
12. Ri-Li Ge, Chase PJ, Witkowski S, et al. Obesity: Associations with acute mountain sickness. Ann of Intern Med. 2003 Aug 19;139(4):253-7.
13. Hsai CC. Mechanisms of disease: Respiratory function of hemoglobin. N Engl J Med. 1998 Jan 22;338(4):239-47.
14. Schoene RB. Limits of human lung function at high altitude. J Exp Biol. 2001 Sep;204(Pt 18):3121-7.
15. Hoppeler H, Vogt M. Muscle tissue adaptations to hypoxia. J Exp Biol. 2001 Sep;204(Pt 18):3133-9.
16. Westerterp KR. Limits to sustainable human metabolic rate. J Exp Biol. 2001 Sep;204(Pt 18):3183-7.
17. The Lake Louise Consensus on the definition and quantification of altitude illness. In: Sutton JR, Coates G, Houston CS (eds). Hypoxia and Mountain Medicine. Burlington, Vermont: Queen City Press, 1992, pp. 327-330.
18. Roach RC, Hackett PH. Frontiers of hypoxia research: Acute mountain sickness. J Exp Biol. 2001 Sept;204(Pt 18):3161-70.
19. Kirsch DB, Jozefowicz RF. Neurologic complications of respiratory disease. Neurol Clin. 2002 Feb;20(1):247-64.
20. Kuo DC, Jerrard DA. Environmental insults: Smoke inhalation, submersion, diving, and high altitude. Emerg Med Clin North Am. 2003 May;21(2):475-97.
21. Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002 Nov;125(Pt 11):2549-57.
22. Yarnell PR, Heit J, Hackett PH. High-altitude cerebral edema (HACE): The Denver/Front Range experience. Semin Neurol. 2000;20(2):209-17.
23. Swenson ER, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema. JAMA. 2002 May 1;287(17):2228-35.
24. Gabry AL, Ledoux X, Mozziconacci M, Martin C. High-altitude pulmonary edema at moderate altitude (< 2,400 m; 7,870 feet): A series of 52 patients. Chest. 2003 Jan;123(1):49-53.
25. Townes DA. Wilderness medicine. Prim Care. 2002 Dec;29(4):1027-48.
26. Hackett JR, Roach RC. High-altitude illness. N Engl J Med. 2001 Jul 12;345(2):107-14.
27. Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary edema. Lancet. 1989 Nov 25;2(8674):1241-4.
28. Hackett PH, Roach RC, Hartig GS, et al. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: A comparison. Int J Sports Med. 1992 Oct;13(Suppl 1):S68-71.
29. Scherrer U, Vollenweider L, Delabays A, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med. 1996 Mar7;334(10):624-9.
30. Purkayastha SS, Ray US, Arora BS, et al. Acclimatization at high altitude in gradual and acute induction. J Appl Physiol. 1995 Aug;79(2):487-92.
31. Berglund B. High-altitude training. Aspects of haematological adaptation. Sports Med. 1992 Nov;14(5):289-303.
32. Burtscher M, Likar R, Nachbauer W, Philadelphy M. Aspirin for prophylaxis against headache at high altitudes: Randomised, double blind, placebo controlled trial. BMJ. 1998 Apr 4;316(7137):1057-8.
33. Schäfer A, Bauersachs J. High-altitude pulmonary edema: Potential protection by red wine. Nutr Metab Cardiovasc Dis. 2002 0ct;12(5):306-10.
34. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med. 2002 May 23;346(21):1631-6.
35. Roncin JP, Schwartz F, et al. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat Space Environ Med. 1996 May;67(5):445-52.